Published in Nanomedicine (Lond) on January 01, 2014
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev (2014) 0.91
A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy. Theranostics (2015) 0.85
Biomimetic particles as therapeutics. Trends Biotechnol (2015) 0.85
Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Res (2015) 0.82
Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model. Int J Mol Sci (2015) 0.81
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis. ACS Nano (2015) 0.81
Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.80
Plasmonic gold nanostars for multi-modality sensing and diagnostics. Sensors (Basel) (2015) 0.78
Non-Spherical Particles for Targeted Drug Delivery. Chem Eng Sci (2015) 0.77
Characterization of Conventional One-Step Sodium Thiosulfate Facilitated Gold Nanoparticle Synthesis. Nanoscale Res Lett (2015) 0.77
An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles. J Biomed Mater Res A (2015) 0.77
Phage display: development of nanocarriers for targeted drug delivery to the brain. Neural Regen Res (2015) 0.76
Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale (2017) 0.75
Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Nanomedicine (Lond) (2016) 0.75
Gold nanocrystals with DNA-directed morphologies. Nat Commun (2016) 0.75
Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery. J Control Release (2015) 0.75
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. Front Immunol (2017) 0.75
Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol (2016) 0.75
Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus (2016) 0.75
Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system. Oncotarget (2017) 0.75
Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells. Cell Mol Bioeng (2017) 0.75
The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages. Nano Lett (2016) 0.75
One-pot synthesis of nanochain particles for targeting brain tumors. Nanoscale (2017) 0.75
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol (2005) 9.70
GPI-anchored proteins are organized in submicron domains at the cell surface. Nature (1998) 8.18
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B (2006) 7.53
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med (1979) 6.00
"Dip-Pen" nanolithography Science (1999) 5.42
Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell (1999) 5.16
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85
The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng (2012) 4.31
GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell (2002) 4.28
Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc (2005) 4.02
Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm (2008) 3.92
A quantitative analysis of the endocytic pathway in baby hamster kidney cells. J Cell Biol (1989) 3.41
Photoinduced conversion of silver nanospheres to nanoprisms. Science (2001) 3.39
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol (2007) 3.36
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res (2000) 3.10
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev (2001) 2.83
Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release (2007) 2.74
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A (1988) 2.74
The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials (2006) 2.71
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther (2008) 2.69
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
Lipid microdomains in cell surface membranes. Curr Opin Struct Biol (1997) 2.66
Impact of polymer tether length on multiple ligand-receptor bond formation. Science (2001) 2.49
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev (2002) 2.19
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
Polymer particle shape independently influences binding and internalization by macrophages. J Control Release (2010) 2.05
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng (2005) 1.97
Building plasmonic nanostructures with DNA. Nat Nanotechnol (2011) 1.95
Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci U S A (1986) 1.95
Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano (2009) 1.95
Tunable plasmonic lattices of silver nanocrystals. Nat Nanotechnol (2007) 1.94
Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther (2006) 1.93
Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials (2007) 1.72
The receptor-mediated endocytosis of nonspherical particles. Biophys J (2008) 1.68
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm (2010) 1.67
Liposomes revisited. Science (1995) 1.66
The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano (2011) 1.65
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology (2009) 1.63
Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci U S A (2013) 1.63
Doxorubicin in sterically stabilized liposomes. Nature (1996) 1.54
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res (1989) 1.47
The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech (2008) 1.46
Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol (2010) 1.45
The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev (1999) 1.45
Novel applications of liposomes. Trends Biotechnol (1998) 1.41
Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc Res (1996) 1.40
Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.40
Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci U S A (2009) 1.38
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A (2013) 1.37
Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett (2012) 1.37
Internalization efficiency of the transferrin receptor. Exp Cell Res (1992) 1.36
Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm (2003) 1.36
Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J Control Release (2010) 1.35
Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors. Biophys J (1999) 1.33
Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm (1999) 1.32
Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. Radiology (1999) 1.32
Monopod, bipod, tripod, and tetrapod gold nanocrystals. J Am Chem Soc (2003) 1.30
Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.30
Ligand-induced endocytosis of epidermal growth factor receptors that are defective in binding adaptor proteins. Proc Natl Acad Sci U S A (1995) 1.28
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release (2003) 1.27
Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release (2010) 1.27
The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials (2012) 1.25
Transvascular drug delivery in solid tumors. Semin Radiat Oncol (1998) 1.23
Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta (2003) 1.21
Sub-two nanometer single crystal Au nanowires. Nano Lett (2008) 1.20
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small (2012) 1.20
Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett (1992) 1.19
Anisotropic etching of silver nanoparticles for plasmonic structures capable of single-particle SERS. J Am Chem Soc (2010) 1.18
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett (1992) 1.17
The zipper mechanism in phagocytosis: energetic requirements and variability in phagocytic cup shape. BMC Syst Biol (2010) 1.17
Synthesis and mechanistic study of palladium nanobars and nanorods. J Am Chem Soc (2007) 1.16
Polygonal gold nanoplates in a polymer matrix. Chem Commun (Camb) (2005) 1.14
One-dimensional colloidal gold and silver nanostructures. Inorg Chem (2006) 1.13
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano (2012) 1.12
Asymmetrically functionalized gold nanoparticles organized in one-dimensional chains. Nano Lett (2008) 1.11
Self-organized silver nanoparticles for three-dimensional plasmonic crystals. Nano Lett (2008) 1.11
Platonic gold nanocrystals. Angew Chem Int Ed Engl (2004) 1.10
The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano (2012) 1.08
Controlled synthesis of gold nanobelts and nanocombs in aqueous mixed surfactant solutions. Langmuir (2008) 1.08
The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology. Ann Biomed Eng (2008) 1.07
Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions. Biochim Biophys Acta (1966) 1.06
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials (2009) 1.06
Determinants of leukocyte margination in rectangular microchannels. PLoS One (2009) 1.06
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med (2006) 1.17
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano (2012) 1.12
Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget (2011) 1.06
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials (2009) 1.06
Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano (2012) 1.03
The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology (2011) 1.00
Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One (2012) 1.00
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging (2013) 0.92
Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry. PLoS One (2011) 0.91
Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release (2003) 0.91
Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano (2013) 0.88
High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent. Magn Reson Med (2009) 0.87
Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine (2009) 0.87
TmDOTA-tetraglycinate encapsulated liposomes as pH-sensitive LipoCEST agents. PLoS One (2011) 0.86
Triggered release of ciprofloxacin from nanostructured agglomerated vesicles. Int J Nanomedicine (2007) 0.81
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J (2012) 0.80
Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Pharm Res (2013) 0.80
Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol (2007) 0.79
On-command drug release from nanochains inhibits growth of breast tumors. Pharm Res (2013) 0.79
Is nanomedicine still promising? Oncotarget (2011) 0.75